Chapter Nine


For fourteen years, as chairman and CEO of Novartis AG, Daniel Vasella, MD, led the Swiss pharmaceutical company through a period of rapid growth with carefully chosen acquisitions, mergers, divestitures, and investments, including in a world-class research facility. Under Vasella's leadership, Novartis developed a diversified portfolio: pharmaceuticals to treat cardiovascular disease, cancer, and other conditions; generic drugs; vaccines; and consumer health products. He also pioneered initiatives to ensure access to medicines, particularly in poorer areas of the world, to treat diseases such as malaria and leprosy. Such distinctions have led Vasella to be honored for his leadership within the pharmaceutical ...

Get No Fear of Failure: Real Stories of How Leaders Deal with Risk and Change now with O’Reilly online learning.

O’Reilly members experience live online training, plus books, videos, and digital content from 200+ publishers.